Cytarabine (CAS 147-94-4) Supplier Information and Product Details

Cytarabine, also known as Ara-C, is an antiviral and anti-tumor drug. It belongs to the category of API intermediates and is used in biochemistry and as a chemical reagent for research and experimental purposes. The compound is a pyrimidine nucleoside ***og that inhibits DNA synthesis.

Synonyms include: - Cytrarabine - Cytosine β-D-arabinofuranoside - Arabinocytidine - 4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone - 4-Amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2(1H)-one

Frequently Asked Questions about Cytarabine

Q: What is the primary use of Cytarabine?

A: Cytarabine is primarily used as an antiviral and anti-tumor drug. It is commonly employed in the treatment of various types of cancer, particularly leukemias.

Q: How does Cytarabine work?

A: Cytarabine works by inhibiting DNA synthesis. It is a pyrimidine nucleoside ***og that interferes with the production of genetic material in rapidly dividing cells, such as cancer cells.

Q: What are the common side effects of Cytarabine?

A: Common side effects may include nausea, vomiting, diarrhea, loss of appetite, and bone marrow suppression leading to decreased blood cell counts. However, specific side effects should be discussed with a healthcare professional.

Q: How is Cytarabine typically administered?

A: Cytarabine is usually administered intravenously or subcutaneously in a clinical setting. The dosage and administration schedule depend on the specific condition being treated and individual patient factors.